S

Surgalign Holdings Inc
F:RT2

Watchlist Manager
Surgalign Holdings Inc
F:RT2
Watchlist
Price: 3.03 EUR -2.73%
Market Cap: €20.1m

Multiples-Based Value

RT2 price has not been updated for more than 6 months. This may indicate that the stock has been delisted.
RT2 doesn't have a meaningful market cap.

There is not enough data to reliably calculate the multiples-based value of RT2.

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

RT2 Multiples-Based Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Multiples Across Competitors

RT2 Competitors Multiples
Surgalign Holdings Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Surgalign Holdings Inc
F:RT2
20.1m EUR 0.3 -0.5 -0.2 -0.2
JP
Hoya Corp
TSE:7741
9.5T JPY 10.4 37.9 27.5 33
US
Medline Inc
NASDAQ:MDLN
55.5B USD 0 0 0 0
CH
Alcon AG
SIX:ALC
29.2B CHF 3.6 38.2 14.7 28.6
DK
Coloplast A/S
CSE:COLO B
97.6B DKK 3.6 24.9 13.1 15.6
US
Align Technology Inc
NASDAQ:ALGN
12.7B USD 3.1 30.9 13.3 18.3
UK
ConvaTec Group PLC
LSE:CTEC
4.4B GBP 2.4 33.8 11.8 18.4
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
38.2B CNY 8.4 23.1 20.8 20.8
CA
Bausch + Lomb Corp
NYSE:BLCO
5.6B USD 1.1 -15.6 16.9 54.6
JP
Asahi Intecc Co Ltd
TSE:7747
870B JPY 6.9 50.3 23.8 32.4
CN
Intco Medical Technology Co Ltd
SZSE:300677
35.8B CNY 3.6 21 31 31
P/E Multiple
Earnings Growth PEG
US
S
Surgalign Holdings Inc
F:RT2
Average P/E: 32.5
Negative Multiple: -0.5
N/A N/A
JP
Hoya Corp
TSE:7741
37.9
14%
2.7
US
M
Medline Inc
NASDAQ:MDLN
Not Available
29%
N/A
CH
Alcon AG
SIX:ALC
38.2
32%
1.2
DK
Coloplast A/S
CSE:COLO B
24.9
21%
1.2
US
Align Technology Inc
NASDAQ:ALGN
30.9
34%
0.9
UK
ConvaTec Group PLC
LSE:CTEC
33.8
41%
0.8
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23.1
9%
2.6
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -15.6 N/A N/A
JP
A
Asahi Intecc Co Ltd
TSE:7747
50.3
38%
1.3
CN
Intco Medical Technology Co Ltd
SZSE:300677
21
12%
1.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
S
Surgalign Holdings Inc
F:RT2
Average EV/EBITDA: 19.2
Negative Multiple: -0.2
N/A N/A
JP
Hoya Corp
TSE:7741
27.5
12%
2.3
US
M
Medline Inc
NASDAQ:MDLN
Not Available
9%
N/A
CH
Alcon AG
SIX:ALC
14.7
9%
1.6
DK
Coloplast A/S
CSE:COLO B
13.1
6%
2.2
US
Align Technology Inc
NASDAQ:ALGN
13.3
14%
0.9
UK
ConvaTec Group PLC
LSE:CTEC
11.8
11%
1.1
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
20.8
13%
1.6
CA
Bausch + Lomb Corp
NYSE:BLCO
16.9
29%
0.6
JP
A
Asahi Intecc Co Ltd
TSE:7747
23.8
12%
2
CN
Intco Medical Technology Co Ltd
SZSE:300677
31
51%
0.6
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett